Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATI-7505 in Postprandial Distress Syndrome
NCT00630370Phase 2Terminated
- Sponsor
- Procter & Gamble
- Start
- Feb 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of naronapride in Postprandial Distress Syndrome (PDS), sponsored by Procter & Gamble. Started Feb 2008; status: terminated.
02
Drugs
naronapride
03
Conditions
Postprandial Distress Syndrome (PDS)
Beyond the preview
Go deeper on NCT00630370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630370.